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INTRODUCTION
Ion mobility mass spectrometry (IMS) is a state-of-the-art technique that first separates gas phase ions based on their mobilities and then based on their m/z ratio.
IMS is known to refine omics workflows by providing cleaner MS and MS/MS spectra thereby facilitating the analyte identification, reducing the false discovery rate
and at the end improving the confidence in results. In addition, IMS improves the data independent (DIA) workflow by applying drift time-based collision energy
thereby drastically improving the spectra quality of the detected features in proteomics studies compared to classical all ions methods where a fixed collision
energy is applied.
In this study we compared the ability of two acquisition modes (classical DDA mode vs. DIA mode) available on the IMS-Q-TOF instrument and two ionization
sources (nano-ESI source vs. ESI) to resolve increasing quantities of complex proteomics samples (E. Coli digest). The identified peptides were compared and the
complementarity between acquisition modes and sources were highlighted.
CONCLUSIONS
Ø Comparison of 2 acquisition modes and separation techniques
Ø Nano ESI is more sensitive than ESI and therefore more suitable for protein contents below 
1 µg
Ø UHPLC-ESI is more interesting to use for protein quantities above 1 µg on column
Ø DIA offers the possibility to detect more proteins compared to DDA
Ø DDA is clearly biased towards highly abundant proteins
Ø Thanks to the absence of precursor selection, DIA allows to detect proteins coming from a 
wider concentration range than DDA
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Ø Ion mobility Q-TOF (Agilent Technologies)
Ø DIA with alternating frame mode
Ø Collision energy applied based on drift time
Ø Computationally aligned precursors and fragments 
Ø Peptide sequencing using Spectrum Mill 
DETECTED ENTITIES
1935 294 2012 184 354 1454
DDA DIA DDA DIA
Peptides Proteins
Ø UHPLC-ESI 
Ø 10 µg of E.Coli digest on-column
Ø Peptides and proteins detected in at least 2 out of 3 replicates
PROTEOME COVERAGE
Ø Endogenous proteins classified by their natural abundances in E. Coli
Ø Classification in deciles 
Ø 10% most abundant proteins account for 88.4% of total protein 
content









































































































































































NanoLC ESI (DDA) UHPLC-ESI (DDA)
NanoLC ESI (DIA) UHPLC-ESI (DIA)
Ø Detected peptides and proteins using both separation techniques and acquisition modes
Ø Each condition was realized in triplicate
Ø Both acquisition modes are complementary and provide additional information to address the biological challenge
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